ArticleInternational journal of peptide research and therapeutics2016

Nebulized Delivery of the MAPKAP Kinase 2 Peptide Inhibitor MMI-0100 Protects Against Ischemia-Induced Systolic Dysfunction.

David I Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.